A drug-Drug interaction study of Lanabecestat (LY3314814) in healthy participants

Trial Identifier: 16014
Sponsor: AstraZeneca
Eli Lilly and Company
NCTID:: NCT02406261
Start Date: April 2015
Primary Completion Date: August 2015
Study Completion Date: August 2015
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, Florida Daytona Beach, Florida, USA, 32117
USA, TX Dallas, TX, USA, 75247